Headache News and Research

Latest Headache News and Research

Delivery of thrombolytic treatment for stroke in Helsinki beats expectations

Neurologists around the world are aware that the delivery of thrombolytic treatment for stroke in Helsinki University Hospital, Finland, is freaking fast - but is it too fast?

13 Jul 2018

Researchers design artificial intelligence system for predicting drug combinations' side effects

Last month alone, 23 percent of Americans took two or more prescription drugs, according to one CDC estimate, and 39 percent over age 65 take five or more, a number that's increased three-fold in the last several decades.

10 Jul 2018

NIH researchers identify natural lipid that acts as potent anti-inflammatory

National Institutes of Health researchers have identified a naturally occurring lipid--a waxy, fatty acid--used by a disease-causing bacterium to impair the host immune response and increase the chance of infection. Inadvertently, they also may have found a potent inflammation therapy against bacterial and viral diseases.

9 Jul 2018

Smartphone headache apps pose privacy risks, study finds

Headache diaries are a mainstay of migraine management, and many commercial smartphone apps have been developed to help people track their pain.

5 Jul 2018

Zika virus-related pregnancy loss in humans may be more common than thought

Fetal death in utero occurred in more than one-fourth of monkeys infected in the laboratory with Zika virus in early pregnancy, according to new research published in Nature Medicine.

3 Jul 2018

PMDA approves use of LYNPARZA in patients with BRCA-mutated breast cancer

AstraZeneca and Merck, known as MSD outside the United States and Canada, today announced that Japan's Pharmaceuticals and Medical Devices Agency has approved LYNPARZA tablets for use in patients with unresectable or recurrent BRCA-mutated, human epidermal growth factor receptor 2 -negative breast cancer who have received prior chemotherapy.

2 Jul 2018

Neurologist suggests maintaining a headache diary to determine and avoid migraine triggers

If you've ever had a migraine, you know it's different from a typical tension headache. A migraine is a type of headache that comes with its own set of symptoms like nausea, sensitivity to light, sound or smells, extreme fatigue or dizziness.

30 Jun 2018

Psychologist suggests few guidelines on how to help children handle scary news

When tragic or violent events occur, parents may wonder about how to help their kids understand the graphic images and emotional video footage that they may see. Stephanie Marcy, PhD, psychologist at Children's Hospital Los angeles suggests a few guidelines to keep in mind so parents can be better equipped to help their children handle scary news.

28 Jun 2018

Researchers identify electrical activity in the brain specific to the start of migraine

When migraine sufferers see the tell-tale squiggly lines, light flashes and blind spots of a migraine aura, they prepare for a migraine.

27 Jun 2018

Merck announces FDA acceptance of supplemental Biologics License Application for KEYTRUDA

Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has accepted for standard review a new supplemental Biologics License Application for KEYTRUDA, Merck's anti-PD-1 therapy, as adjuvant therapy in the treatment of patients with resected, high-risk stage III melanoma and granted a Prescription Drug User Fee Act, or target action, date of February 16, 2019.

25 Jun 2018

Alcohol hangovers more significant and costly than people realize, shows research

Alcohol hangovers are more significant and costly than people realize, new research shows. Although individuals may be "street legal" to drive a car, or go to work and operate machinery, they can be just as impaired with a hangover as if they were over the alcohol limit.

20 Jun 2018

Study shows how moderate consumption of alcohol can protect the heart

For at least 20 years, research has shown that for many people, moderate consumption of alcohol can protect the heart, but the reason for this is poorly understood.

18 Jun 2018

New study focuses on best, cost effective practices to bridge treatment gap for brain disorders

Up to eight out of ten patients with a brain disorder remain untreated or inadequately treated. But what is the best practice - and above all, most cost effective - healthcare interventions to bridge the treatment gap? This was the focus of the European Brain Council's study entitled The Value of Treatment which was discussed at the Congress of the European Academy of Neurology in Lisbon.

18 Jun 2018

Alnylam announces new positive results from Phase 1/2 study of lumasiran in patients with PH1

Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, announced today new positive results from its Phase 1/2 study with lumasiran, an investigational RNAi therapeutic targeting glycolate oxidase for the treatment of Primary Hyperoxaluria Type 1.

8 Jun 2018

Opdivo plus low-dose Yervoy shows promising results in treating renal cell carcinoma patients

Bristol-Myers Squibb Company today announced patient-reported outcomes data from the Phase 3 CheckMate -214 trial in intermediate- and poor-risk patients with advanced renal cell carcinoma treated with the Immuno-Oncology combination Opdivo plus low-dose Yervoy versus sunitinib over a two-year follow-up period.

1 Jun 2018

FDA approves first oral medication for adults with moderately to severely active ulcerative colitis

The U.S. Food and Drug Administration today expanded the approval of Xeljanz (tofacitinib) to include adults with moderately to severely active ulcerative colitis. Xeljanz is the first oral medication approved for chronic use in this indication.

30 May 2018

Limiting global warming could reduce millions of dengue cases every year

Limiting global warming to 1.5°C could avoid around 3.3 million cases of dengue fever per year in Latin America and the Caribbean alone - according to new research from the University of East Anglia.

28 May 2018

FDA approves novel enzyme therapy for adults with rare and serious genetic disease

The U.S. Food and Drug Administration today approved Palynziq (pegvaliase-pqpz) for adults with a rare and serious genetic disease known as phenylketonuria (PKU).

25 May 2018

NIH commences first-in-human trial evaluating experimental treatment for Ebola

A first-in-human trial evaluating an experimental treatment for Ebola virus disease has begun at the National Institutes of Health (NIH) Clinical Center in Bethesda, Maryland.

24 May 2018

Celgene to share new and updated data around novel hematological therapies

Celgene Corporation today announced that data from a broad range of early and late stage studies evaluating Celgene investigational agents and investigational uses of marketed products will be presented at the 23rd European Hematology Association annual meeting in Stockholm, Sweden, from June 14-17, 2018.

22 May 2018

Headache News and Research

Latest Headache News and Research

Delivery of thrombolytic treatment for stroke in Helsinki beats expectations

Researchers design artificial intelligence system for predicting drug combinations' side effects

NIH researchers identify natural lipid that acts as potent anti-inflammatory

Smartphone headache apps pose privacy risks, study finds

Zika virus-related pregnancy loss in humans may be more common than thought

PMDA approves use of LYNPARZA in patients with BRCA-mutated breast cancer

Neurologist suggests maintaining a headache diary to determine and avoid migraine triggers

Psychologist suggests few guidelines on how to help children handle scary news

Researchers identify electrical activity in the brain specific to the start of migraine

Merck announces FDA acceptance of supplemental Biologics License Application for KEYTRUDA

Alcohol hangovers more significant and costly than people realize, shows research

Study shows how moderate consumption of alcohol can protect the heart

New study focuses on best, cost effective practices to bridge treatment gap for brain disorders

Alnylam announces new positive results from Phase 1/2 study of lumasiran in patients with PH1

Opdivo plus low-dose Yervoy shows promising results in treating renal cell carcinoma patients

FDA approves first oral medication for adults with moderately to severely active ulcerative colitis

Limiting global warming could reduce millions of dengue cases every year

FDA approves novel enzyme therapy for adults with rare and serious genetic disease

NIH commences first-in-human trial evaluating experimental treatment for Ebola

Celgene to share new and updated data around novel hematological therapies

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Headache News and Research

Latest Headache News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in